Found 6 matching trials
Treatment of Cutaneous Leishmaniasis With a Combination of Miltefosine and Antimony PHASE2 Cutaneous leishmaniasis is endemic in the New World and, until recently, th...
Show More Learn More & Join Trial
Treatment of Mucosal Bolivian Leishmaniasis PHASE3 The purpose of this protocol is to conduct a randomized comparison of the e...
Show More Location
Hospital Dermatologico de Jorochito
Learn More & Join Trial
Short Course of Miltefosine and Antimony to Treat Cutaneous Leishmaniasis in Bolivia PHASE2 The combination of a half-course of miltefosine and a half-course of antimo...
Show More Location
Hospital Dermatológico
Learn More & Join Trial
Miltefosine/Paromomycin Phase III Trial for Treatment of Primary Visceral Leishmaniasis (VL) Patients in Eastern Africa PHASE3 This is an open label, Phase III, randomized, controlled, parallel arm mult...
Show More Location
Abdurafi MSF Health Center
Learn More & Join Trial
Clinical Trial to Assess the Safety and Efficacy of Sodium Stibogluconate (SSG) and AmBisome® Combination, Miltefosine and AmBisome® and Miltefosine Alone for the Treatment Visceral Leishmaniasis in Eastern Africa PHASE2 This study is to assess if shorter combinations of SSG plus single dose AmB...
Show More Location
Kimalel Health Centre
Learn More & Join Trial
Oral Miltefosine for the Treatment of Pediatric Cutaneous Leishmaniasis in Colombia PHASE3 The purpose of this randomized, open label clinical trial is to determine i...
Show More Location
Multiple Locations
Learn More & Join Trial